^
Association details:
Evidence:
Evidence Level:
Sensitive: D – Preclinical
New
Source:
Title:

Pim Kinase Inhibitor Enhances FLT3 Inhibitor Efficacy through GSK-3ß Activation and GSK-3ß-Mediated Proteasomal Degradation of c-Myc

Published date:
11/04/2021
Excerpt:
Ba/F3-ITD and MV4-11 cells, with FLT3-ITD, and FLT3-ITD AML patient blasts were cultured with the pan-Pim inhibitor AZD1208 (1 μM) and/or the FLT3 inhibitors gilteritinib or quizartinib...Treatment with Pim inhibitor AZD1208 and FLT3 inhibitor gilteritinib or quizartinib combination…Concurrent treatment of cells with FLT3-ITD with Pim kinase inhibitor enhances the efficacy of FLT3 inhibitors.
DOI:
10.1182/blood-2021-151737